跳转至内容
Merck
CN

Medical therapy for acquired urinary incontinence in dogs.

International journal of pharmaceutical compounding (2012-10-18)
Katie Hill, Dinah Jordan, Jody Ray, Andrew A Mays, Katie Griffin
摘要

The objective of this case report was to review acquired canine urethral incontinence in a case of a 2-year-old beagle that presented for inappropriate urination. Commercially available medications, as well as compounded medical therapeutic options, were reviewed. Diagnostic results revealed cystitis, which responded to the prescribed antibiotics. The incontinence issue remained. Compounded diethylstilbestrol was prescribed and dispensed to achieve successful clinical results. The role of the compounding pharmacist was vital to achieve appropriate dosing of a drug no longer commercially available.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
己烯雌酚, ≥99% (HPLC)
Supelco
雌三醇 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
雌三醇, meets USP testing specifications
Supelco
己烯雌酚, VETRANAL®, analytical standard